SavedAdd your journal

Journals / Anestezi Dergisi / 2005 / Cilt: 13 - Sayı: 2

Extracorporeal coagulation and hemostasis

Vücut dışı dolaşımda koagülasyon ve hemostaz

Meral KANBAK
Pages
83–95
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Alter-native agents have been developed in cases where these drugs are contra-indicated. in this review, the physiology of coagulation and the effects of ECC on hemostasis are presented and precautions and clinicalpractice are overviewed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Application of extracorporeal circulation SfiCC) in patients undergoing öpen heart surgery affects the hemostatic system detrimentally.
📊
Key Findings & Data:The interaction of heparinised blood in the ECC with nonendothelial biomaterial leads to thrombin formation.
💡
Conclusion & Impact:Alter-native agents have been developed in cases where these drugs are contra-indicated. in this review, the physiology of coagulation and the effects of ECC on hemostasis are presented and precautions and clinicalpractice are overviewed.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Kalp cerrahi işlemleri · Hemostaz · Heparin

Abstract

Application of extracorporeal circulation SfiCC) in patients undergoing öpen heart surgery affects the hemostatic system detrimentally. The interaction of heparinised blood in the ECC with nonendothelial biomaterial leads to thrombin formation. Furthermore, induced hypothermia, drugs, and hemodilution activate the coagulation system and cause platelet dysfunction. Both Heparin, usedfor anti-coagulation during ECC, and Protamine, which is usedfor reversal, have many side effects. Alter-native agents have been developed in cases where these drugs are contra-indicated. in this review, the physiology of coagulation and the effects of ECC on hemostasis are presented and precautions and clinicalpractice are overviewed.

Özet

Açık kalp cerrahisi uygulanan hastalarda vücut dışı dolaşımın (VDD) kullanılması hemostatik sistemi olumsuz yönde etkilemektedir. Heparinize kanın VDD devrelerinde nonendotelyal biyomateryal yüzeylerle etkileşimi trombin oluşumuna yol açmaktadır. Ayrıca uygulanan hipotermi, ilaçlar ve hemodilüsyon koagülasyon sistemini aktive etmekte ve trombosit fonksiyonlarını bozmaktadır. VDD sırasında antikoagülasyon için kullanılan heparinin ve bunu nötralize etmek için uygulanan protaminin de pek çok yan etkisi vardır. Bu ilaçların kontrendike olduğu durumlar için alternatif ilaçlar geliştirilmiştir. Bu derlemede koagülasyonun fizyolojisi ve VDD'in hemostaz üzerine etkileri irdelenmiş, alınması gereken tedbir ve uygulamalar gözden geçirilmiştir.

🔖

Cite This Article

KANBAK, M. (2005). Extracorporeal coagulation and hemostasis. Anestezi Dergisi, Cilt: 13 - Sayı: 2, 83–95. https://ajindex.com/articles/355231

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Colman RW, Marder VJ, Salzman EW, Hirsh J. Overview in hemostasis. in Colman Colman RW; Hirsh J, Marder VJ, Clowes AW, Georğe JN (eds) Hemostasis and Thrombosis: Basic Principles and Practice. Philadelphia, Lippincott, Williams and Wilkins,2001, 3-17
  2. Horrow J. Transfusion medicine and coagulation disorders, in Cardiac Anesthesia Kaplan JA (Ed). Fourth edition, Philadelphia, Pennsylvania, Saunders Company, 1999, 111-54
  3. Edmunds LH, Colman RW. Extracorporeal circulation.Thrombosis and Bleeding. In Conn LH, Edmounds LH (Eds). Cardiac surgery in the adult. Second edition. Newyork, McGraw-Hill, 2003,338-48
  4. Horbett TA. Principles underlying the role of adsorbed plsma proteins in blood interactions with foreign materials. Cardiovasc Pathol 1993; 2: 137S
  5. Boisclair MD, Lane DA, Philippou H, et al: Thrombin production, inactivation and expression during open heart surgery measured by assays for activation fragments including a new ELISA for prothrombin Fragment Fl + 2. Thromb Haemost 1993; 70 (2):253-8
  6. Colman RW. Contact activation pathway: Inflammatory, fibrinolytic, anticoagulant, antiadhesive and antiangiogenic activities. In Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN (eds) Hemostasis and Thrombosis: Basic Principles and Practice. Philadelphia, Lippincott, Williams and Wilkins 2001; 103-21
  7. Wachtfogel YT, Harpel PC, Edmunds LH Jr, Colman RW. Formation of Cls-Cl-inhibitor, kallikrein-Cl-inhibitor, and plasmin-alpha 2-plasmin-inhibitor complexes during cardiopulmonary by pass. Blood 1989; 73 (2): 468-71 8. Walsh PN. Factor XL In Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN (eds) Hemostasis and Thrombosis: Basic Principles and Practice. Philadelphia, Lippincott, Williams and Wilkins 2001;191-201
  8. Chung JH, Gikakis N, Rao AK, Drake TA, Colman RW, Edmunds LH Jr. Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass. Circulation 1996; 93 (11): 2014-8
  9. Jenny NS, Ann KG. Thrombin. In Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN (eds) Hemostasis and Thrombosis: Basic Principles and Practice. Philadelphia, Lippincott, Williams and Wilkins, 2001,171-90
  10. Blister SJ, Ofosu FA, Buchanan MR. Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant? Thromb Haemost 1993; 70 (2): 259-62
  11. Gorman RC, Ziats NP, Gikakis N, et al. Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass. JThorac Cardiovasc Surg 1996;